QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Doug Lakin who wrote ()	10/4/1999 2:50:00 PM
From: Ian@SI	Read Replies (1) of 1321

Big smiles on November 18th??? ++++++= October 4, 1999 FDA To Review Ciba/QLT PhotoTherapeutics NDA On Nov. 17 ATLANTA (Dow Jones)--QLT PhotoTherapeutic Inc. (QLTI) and Novartis AG's Ciba Vision Corp. unit said the Food and Drug Administration will begin reviewing the companies' New Drug Application for its Visudyne therapy on Nov. 17. In a press release Monday, Ciba said Visudyne treats wet age-related macular degeneration. The medical products company said it expects to put Visudyne on the market early next year. As reported Aug. 23, the FDA assigned priority review status to the application for Visudyne, indicating it would act on the application within six months. -Roy R. Reynolds

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next